SRIDHAR MANI, MD
Osteopathic Medicine at Eastchester Rd, Bronx, NY
License number
New York 186785
Category
Osteopathic Medicine
Type
Medical Oncology
Address
Address
1695 Eastchester Rd, Bronx, NY 10461
Phone
(718) 405-8505
(718) 904-2830 (Fax)
(718) 904-2830 (Fax)
Personal information
See more information about SRIDHAR MANI at radaris.comName
Address
Phone
2500 Johnson Ave APT 8G, Bronx, NY 10463
Bronx, NY
2500 Johnson Ave, Bronx, NY 10463
Organization information
See more information about SRIDHAR MANI at bizstanding.comSridhar Mani MD
1825 Eastchester Rd, Bronx, NY 10461
Industry:
Internist
Phone:
(718) 904-2488 (Phone)
Sridhar Mani
Professional information
Sridhar Mani, Bronx NY
Specialties:
Oncologist
Address:
1695 Eastchester Rd, Bronx, NY 10461
1825 Eastchester Rd, Bronx, NY 10461
111 E 210Th St, Bronx, NY 10467
1825 Eastchester Rd, Bronx, NY 10461
111 E 210Th St, Bronx, NY 10467
Education:
Doctor of Medicine*
Board certifications:
American Board of Internal Medicine Certification in Internal Medicine*, American Board of Internal Medicine Sub-certificate in Oncology (Internal Medicine)*
Dr. Sridhar Mani, Bronx NY - MD (Doctor of Medicine)
Specialties:
Oncology, Medical Oncology
Address:
1825 Eastchester Rd SUITE 2548, Bronx 10461
(718) 904-2488 (Phone), (718) 904-2830 (Fax)
ALBERT EINSTEIN CANCER CENTER
1825 Eastchester Rd, Bronx 10461
(718) 904-2754 (Phone), (718) 904-2830 (Fax)
(718) 904-2488 (Phone), (718) 904-2830 (Fax)
ALBERT EINSTEIN CANCER CENTER
1825 Eastchester Rd, Bronx 10461
(718) 904-2754 (Phone), (718) 904-2830 (Fax)
Certifications:
Internal Medicine, 2013, Medical Oncology, 2007
Awards:
Healthgrades Honor Roll
Languages:
English, French
Hospitals:
1825 Eastchester Rd SUITE 2548, Bronx 10461
ALBERT EINSTEIN CANCER CENTER
1825 Eastchester Rd, Bronx 10461
Montefiore Medical Center
111 East 210Th St, Bronx 10467
ALBERT EINSTEIN CANCER CENTER
1825 Eastchester Rd, Bronx 10461
Montefiore Medical Center
111 East 210Th St, Bronx 10467
Education:
Medical School
Mount Sinai School of Medicine
Graduated: 1990
Yale New Haven Hospital
Mount Sinai School of Medicine
Graduated: 1990
Yale New Haven Hospital
Selective Beta-Glucuronidase Inhibitors As A Treatment For Side Effects Of Camptothecin Antineoplastic Agents
US Patent:
2012032, Dec 20, 2012
Filed:
Dec 9, 2010
Appl. No.:
13/514418
Inventors:
Matthew R. Redinbo - Durham NC, US
Sridhar Mani - Riverdale NY, US
Alfred Williams - Durham NC, US
John Scott - Durham NC, US
Li-An Yeh - Cary NC, US
Bret David Wallace - Chapel Hill NC, US
Kimberly Terry Lane - Christiansburg VA, US
Sridhar Mani - Riverdale NY, US
Alfred Williams - Durham NC, US
John Scott - Durham NC, US
Li-An Yeh - Cary NC, US
Bret David Wallace - Chapel Hill NC, US
Kimberly Terry Lane - Christiansburg VA, US
Assignee:
THE UNIVERSITY OF NORTH CAROLINA AT CHAPEL HILL - Chapel Hill NC
NORTH CAROLINA CENTRAL UNIVERSITY - Durham NC
ALBERT EINSTEIN COLLEGE OF MEDICINE OF YESHIVA UNIVERSITY - Bronx NY
NORTH CAROLINA CENTRAL UNIVERSITY - Durham NC
ALBERT EINSTEIN COLLEGE OF MEDICINE OF YESHIVA UNIVERSITY - Bronx NY
International Classification:
A61K 31/4704, A61P 31/04, C07D 333/38, A61K 31/381, A61K 31/5377, A61K 31/496, C07D 487/04, C07D 405/10, C07D 495/14, C07D 215/227, C07D 495/04
US Classification:
5142328, 546157, 514312, 549 68, 514447, 544278, 51425216, 544281, 544377, 51425411, 544112
Abstract:
Compounds, compositions and methods are provided that comprise selective β-glucuronidase inhibitors for both aerobic and anaerobic bacteria, especially enteric bacteria normally associated with the gastrointestinal tract. The compounds, compositions and methods can be for inhibiting bacterial β-glucuronidases and for improving efficacy of camptothecin-derived antineoplastic agents or glucuronidase-substrate agents or compounds by attenuating the side effects caused by reactivation by bacterial β-glucuronidases of glucuronidated metabolites of camptothecin-derived antineoplastic agents or glucuronidase-substrate agents or compounds.
Sensitization Of Cells To Cytotoxic Agents Using Oligonucleotides Directed To Nucleotide Excision Repair Or Transcritpion Coupled Repair Genes
US Patent:
2003023, Dec 18, 2003
Filed:
Apr 3, 2001
Appl. No.:
09/825489
Inventors:
Sudhir Agrawal - Shrewsbury MA, US
Ekambar Kandimalla - Southboro MA, US
David Bregman - Trumbull CT, US
Sridhar Mani - Riverdale NY, US
Yi Lu - Bronx NY, US
Ekambar Kandimalla - Southboro MA, US
David Bregman - Trumbull CT, US
Sridhar Mani - Riverdale NY, US
Yi Lu - Bronx NY, US
International Classification:
A61K048/00, A61K031/28, A61K033/24, A61K033/40
US Classification:
514/044000, 424/649000, 424/616000, 514/492000, 600/001000
Abstract:
This invention relates to the fields of molecular biology and oncology. More particularly, this invention relates to the sensitization of cancerous cells to therapeutic agents. The invention provides methods, compositions, and formulations for potentiating or enhancing the toxicity of various cytotoxins and oxidizing agents, and of reducing the resistance and proliferation rate of cancer cells. It also provides various compositions and therapeutic formulations useful as anticancer agents.
Antisense Oligonucleotides And Methods To Induce Tumor Cell Death
US Patent:
2003012, Jul 3, 2003
Filed:
Sep 24, 2002
Appl. No.:
10/253132
Inventors:
Ekambar Kandimalla - Southboro MA, US
Sudhir Agrawal - Shrewsbury MA, US
Sai Shankar - New York NY, US
Sridhar Mani - Riverdale NY, US
Sudhir Agrawal - Shrewsbury MA, US
Sai Shankar - New York NY, US
Sridhar Mani - Riverdale NY, US
Assignee:
Hybridon, Inc.
International Classification:
A61K048/00, C12Q001/68, C07H021/04, C12N005/02
US Classification:
514/044000, 435/006000, 435/375000, 536/023500
Abstract:
This invention relates to the inhibition and down-regulation of survivin expression. The invention provides methods and antisense oligonucleotides for inhibiting or down-regulating survivin expression in cells and promoting apoptosis and cell necrosis.
Ketoconazole-Derivative Antagonist Of Human Pregnane X Receptor And Uses Thereof
US Patent:
2011010, May 5, 2011
Filed:
Jan 27, 2009
Appl. No.:
12/735368
Inventors:
Sridhar Mani - Riverdale NY, US
Bhaskar C. Das - West Nyack NY, US
Bhaskar C. Das - West Nyack NY, US
International Classification:
A61K 31/496, C07D 405/12, C07D 317/30, C12N 5/09, A61P 35/00
US Classification:
5142541, 544374, 544230, 549452, 435375
Abstract:
The application discloses ketoconazole derivatives that are antagonists of the human pregnane X receptor (PXR), methods of preparing the derivatives, uses of the derivatives with drug therapy, and methods of inhibiting tumor cell proliferation and multidrug resistance using inhibitors of PXR.
Hypoxia Targeted Compounds For Cancer Diagnosis And Therapy
US Patent:
2011025, Oct 13, 2011
Filed:
Nov 18, 2009
Appl. No.:
12/998703
Inventors:
Bhaskar Chandra Das - West Nyack NY, US
Sridhar Mani - Riverdale NY, US
Sridhar Mani - Riverdale NY, US
International Classification:
A61K 31/536, C07D 265/36, A61P 35/00, C12N 5/09
US Classification:
5142305, 435375, 544105
Abstract:
The present invention generally relates to oxazine derivative compounds and related compositions and methods for inducing hypoxic tumor cell death, treating cancer and locating a hypoxic tumor in a subject.